These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1970766)

  • 21. Stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil: species differences and influence of endotoxin.
    Laethem ME; Belpaire FM; Wijnant P; Bogaert MG
    Chirality; 1995; 7(8):616-22. PubMed ID: 8593255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucuronidation of propranolol and 4'-hydroxypropranolol. Substrate specificity and stereoselectivity of rat liver microsomal glucuronyltransferases.
    Thompson JA; Hull JE; Norris KJ
    Drug Metab Dispos; 1981; 9(5):466-71. PubMed ID: 6117447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
    Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW
    Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of CYP2D6 poor metabolizer phenotype on propranolol pharmacokinetics and response.
    Sowinski KM; Burlew BS
    Pharmacotherapy; 1997; 17(6):1305-10. PubMed ID: 9399616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children.
    Kauffman RE; Lieh-Lai MW; Uy HG; Aravind MK
    Clin Pharmacol Ther; 1999 Apr; 65(4):382-8. PubMed ID: 10223774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites.
    Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
    J Pharmacol Exp Ther; 1987 Jun; 241(3):928-33. PubMed ID: 3598909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
    Paradiso-Hardy FL; Walker SE; Bowles SK
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.
    Hussein Z; Mulford DJ; Bopp BA; Granneman GR
    Drug Metab Dispos; 1993; 21(5):805-10. PubMed ID: 7902240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosol.
    Narimatsu S; Kobayashi N; Asaoka K; Masubuchi Y; Horie T; Hosokawa M; Ishikawa T; Ohmori S; Kitada M; Miyano J; Kataoka H; Yamamoto S
    Chirality; 2001; 13(3):140-7. PubMed ID: 11270323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
    Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
    Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interspecies differences in stereoselective protein binding and clearance of MK-571.
    Tocco DJ; deLuna FA; Duncan AE; Hsieh JH; Lin JH
    Drug Metab Dispos; 1990; 18(4):388-92. PubMed ID: 1976057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of diltiazem versus cimetidine on propranolol metabolism.
    Tateishi T; Ohashi K; Fujimura A; Ebihara A
    J Clin Pharmacol; 1992 Dec; 32(12):1099-104. PubMed ID: 1487547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration.
    Imai T; Yoshigae Y; Hosokawa M; Chiba K; Otagiri M
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1234-42. PubMed ID: 14534358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, enantiomer interconversion, and metabolism of R-apomorphine in patients with idiopathic Parkinson's disease.
    van der Geest R; van Laar T; Kruger PP; Gubbens-Stibbe JM; Boddé HE; Roos RA; Danhof M
    Clin Neuropharmacol; 1998; 21(3):159-68. PubMed ID: 9617507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical aspects of propranolol metabolism. Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)propane-1,2-diol as a metabolite of propranolol in the dog, in man and in the rat liver 9000g supernatant fraction.
    Gupte SM; Bartels MJ; Kerr BM; Laganiere S; Silber BM; Nelson WL
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):235-44. PubMed ID: 6658188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetics of propranolol, phenytoin and lidocaine in hypercholesterolemic rabbits].
    Vinçon G; Ploux D; Pehourcq F; Albin H
    J Pharmacol; 1983; 14(1):47-55. PubMed ID: 6834851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation, purification, and structure identification of glucuronic acid conjugates of propranolol and alprenolol and their ring-hydroxylated metabolites.
    Bai SA; Walle T
    Drug Metab Dispos; 1984; 12(6):749-54. PubMed ID: 6150825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacologic effects of the S(-) isomer of bupivacaine after intravenous and epidural administration in dogs.
    Franquelo C; Toledo A; Manubens J; Valladares JE; Cristòfol C; Arboix M
    Am J Vet Res; 1999 Jul; 60(7):832-5. PubMed ID: 10407475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.